https://demo.pharmafocusasia.com/technotrends/relay-therapeutics-receives-breakthrough-therapy 2026-04-27 09:44:52 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-receives-breakthrough-therapy 2026-04-27 09:43:31 daily 0.1 https://demo.pharmafocusasia.com/technotrends/neurogene-introduces-breakthrough-ngn-401 2026-04-27 09:42:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/encoded-therapeutics-has-introduced-etx101 2026-03-16 03:45:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sanofi-introduces-breakthrough-rilzabrutinib 2026-03-16 03:45:00 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novartis-introduces-breakthrough-ianalumab 2026-03-16 03:44:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/protara-therapeutics-introduces-breakthrough-tara-002 2026-02-26 23:53:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/immix-biopharma-introduces-breakthrough-nxc-201 2026-02-26 23:52:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ipsen-introduces-breakthrough-ipn60340-ict01 2026-02-26 23:49:37 daily 0.1 https://demo.pharmafocusasia.com/technotrends/altimmune-introduces-breakthrough-pemvidutide 2026-02-26 23:50:34 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ionis-pharmaceuticals-introduces-breakthrough-ion582 2025-11-25 07:32:31 daily 0.1 https://demo.pharmafocusasia.com/technotrends/spruce-biosciences-introduces-breakthrough 2025-11-25 07:35:31 daily 0.1 https://demo.pharmafocusasia.com/technotrends/daiichi-sankyo-and-merck-introduce-breakthrough 2025-11-25 07:29:48 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indias-drug-manufacturing-sector-secures-major-foreign-investment 2025-10-12 00:06:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-regulatory-body-issues-new-guidelines-for-biopharmaceuticals 2025-10-12 00:06:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/innovative-manufacturing-solutions-transforming-drug-production-in-india 2025-10-09 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-new-regulatory-framework-to-accelerate-biopharma-rd-investments 2025-10-09 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indias-major-investment-in-biotech-startups-to-drive-innovation 2025-10-07 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-new-drug-approval-process-streamlined-to-boost-biopharma-innovation 2025-10-07 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/japans-ministry-of-health-announces-new-clinical-trial-guidelines-focusing-on-data-integrity 2025-10-06 00:06:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-national-medical-products-administration-enhances-regulatory-framework-for-biologics 2025-10-06 00:06:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/japan-approves-new-regulations-for-the-manufacturing-of-high-purity-biologics 2025-10-05 00:06:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indias-biopharma-sector-sees-surge-in-rd-investment-amid-global-collaborations 2025-10-05 00:06:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/japan-plans-to-boost-biotechnology-investments-through-new-public-private-partnership-initiatives 2025-10-02 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-national-medical-products-administration-introduces-new-regulations-to-streamline-clinical-trial-approvals 2025-10-02 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-new-drug-approval-regulations-aim-to-expedite-market-entry-for-biologics 2025-09-29 00:06:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indias-oncoone-expands-oncology-rd-collaborations-in-southeast-asia 2025-09-29 00:06:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indias-biotech-sector-experiences-surge-in-investment-amid-global-challenges 2025-09-26 00:06:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-new-regulatory-reforms-for-drug-approvals 2025-09-26 00:06:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/regulatory-changes-in-asean-to-boost-pharmaceuticals-trade-and-collaboration 2025-09-25 00:06:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/asias-biopharma-sector-sees-increased-rd-investment-to-accelerate-drug-development 2025-09-25 00:06:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/daiichi-sankyo-and-merck-introduce-breakthrough-ifinatamab 2025-09-24 07:36:20 daily 0.1 https://demo.pharmafocusasia.com/technotrends/precigen-unveils-first-and-only-papzimeos 2025-09-24 07:35:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indias-biotech-sector-sees-surge-in-investment-amid-r-d-innovations 2025-09-24 00:06:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chinas-new-regulations-to-enhance-efficiency-in-drug-manufacturing 2025-09-24 00:06:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/singapore-government-unveils-new-biopharmaceutical-manufacturing-facilities-to-boost-production-capacity 2025-09-21 00:06:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/taiwans-biomedical-industry-sees-surge-in-investment-amid-regulatory-reforms 2025-09-21 00:06:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/dyne-therapeutics-introduces-breakthrough-dyne-251-for-the-treatment 2025-09-20 04:33:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/antengene-introduces-breakthrough-atg-022-for-the-treatment 2025-09-20 04:29:49 daily 0.1 https://demo.pharmafocusasia.com/technotrends/china-approves-new-regulatory-framework-for-clinical-trials 2025-09-20 00:06:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/singapore-launches-new-initiative-to-boost-biopharmaceutical-innovation 2025-09-20 00:06:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/china-strengthens-regulations-on-biotech-drug-approvals-to-enhance-market-access 2023-10-04 23:00:00 daily 0.1 https://demo.pharmafocusasia.com/technotrends/india-scrutinizes-biologics-and-biosimilars-with-new-evaluation-guidelines 2025-09-18 00:06:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/china-implements-new-regulatory-framework-for-biopharmaceutical-innovation 2025-09-18 00:06:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/japan-introduces-new-regulatory-framework-for-biosimilars-to-expedite-market-entry 2025-09-13 00:06:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/astrazeneca-and-roche-announce-strategic-partnership-to-advance-oncology-research-in-asia 2025-09-13 00:06:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/avidity-biosciences-introduces-breakthrough-del-zota-for-the-treatment 2025-08-13 07:23:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/revolution-medicines-introduces-breakthrough-elironrasib 2025-08-06 07:01:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/praxis-precision-medicines-introduces-breakthrough-relutrigine 2025-07-24 06:55:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/daiichi-sankyo-introduces-enhertu-plus-pertuzumab 2025-07-24 06:54:04 daily 0.1 https://demo.pharmafocusasia.com/technotrends/dyne-therapeutics-introduces-breakthrough-dyne-101 2025-07-10 06:23:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cellectar-introduces-breakthrough-radiotherapeutic-iopofosine 2025-07-10 06:23:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novartis-unveils-first-and-only-fabhalta-iptacopan-for-the-treatment 2025-05-23 01:28:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/innovent-biologics-launches-first-in-class-igf-1r-monoclonal-antibody 2025-04-29 07:12:05 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uniqure-introduces-breakthrough-gene-therapy-amt-130-for-the-treatment 2025-04-29 07:10:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/brainchild-bio-introduces-breakthrough-b7-h3-car-t-cell-therapy 2025-04-29 07:09:31 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-introduced-first-and-only-rybrevant-for-non-small 2025-04-09 03:21:46 daily 0.1 https://demo.pharmafocusasia.com/technotrends/genentech-unveils-first-and-only-susvimo-for-the-treatment 2025-04-09 03:20:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/alnylam-introduced-first-and-only-amvuttra-vutrisiran 2025-04-07 01:03:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-unveils-first-and-only-tremfya-guselkumab 2025-04-07 00:43:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/genentech-unveils-first-and-only-tnkase 2025-03-11 03:25:25 daily 0.1 https://demo.pharmafocusasia.com/technotrends/fapon-biopharma-launches-first-in-class-fp008-immunotherapy-for-solid-tumours 2025-03-11 03:24:20 daily 0.1 https://demo.pharmafocusasia.com/technotrends/grin-therapeutics-introduces-breakthrough-radiprodil 2025-03-11 03:23:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/neurotech-pharmaceuticals-unveils-first-and-only-encelto 2025-03-11 03:22:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/gsk-discovers-gsk227-for-relapsed-or-refractory-osteosarcoma 2025-01-27 03:23:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/rezolute-unveils-breakthrough-ersodetug-for-hypoglycemia-patients 2025-01-27 03:22:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/gilead-sciences-discovers-trodelvy-for-extensive-stage-small-cell-lung-cancer 2025-01-05 23:26:48 daily 0.1 https://demo.pharmafocusasia.com/technotrends/gsk-unveils-breakthrough-jemperli-for-advanced-dmmrmsi-h-rectal-cancer 2025-01-05 23:24:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/eli-lilly-introduced-first-and-only-zepbound-for-obstructive-sleep-apnoea 2025-01-04 01:25:46 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-launches-first-line-treatment-for-mutant-metastatic-colourectal-cancer 2025-01-04 01:24:32 daily 0.1 https://demo.pharmafocusasia.com/technotrends/hutchmed-discovers-novel-orpathys-and-tagrisso-combination 2024-12-22 23:58:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sanofi-introduces-breakthrough-tolebrutinib-for-non-relapsing-secondary 2024-12-22 23:57:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/stoke-therapeutics-introduced-breakthrough-zorevunersen-for-the-treatment 2024-12-13 06:45:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/merck-develops-novel-sacituzumab-tirumotecan-for-advanced-nsclc-treatment 2024-12-13 06:44:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/inxmed-unveils-lfebemtinib-for-first-line-non-small-cell-lung-cancer 2024-12-07 00:01:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/huahui-health-launches-novel-libevitug-hh-003-for-treatment-of-chronic 2024-12-07 00:00:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/syndax-launches-revuforj-for-relapsedrefractory-acute-leukemia-treatment 2024-11-26 06:40:42 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-unveils-first-and-only-nipocalimab-for-the-treatment 2024-11-26 06:39:38 daily 0.1 https://demo.pharmafocusasia.com/technotrends/fresenius-kabi-launches-tyenne-the-first-tocilizumab-biosimilar 2024-11-08 04:28:27 daily 0.1 https://demo.pharmafocusasia.com/technotrends/hansoh-pharmaceutical-group-introduces-breakthrough-b7-h3-targeted 2024-11-08 04:27:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ultragenyx-pharmaceutical-developed-first-of-its-kind-setrusumab 2024-10-16 00:10:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/boehringer-ingelheim-discovered-novel-survodutide-for-the-treatment-of-advanced-fibrosis 2024-10-16 00:09:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/arrowhead-pharmaceuticals-develops-novel-plozasiran 2024-09-27 07:00:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/genentech-unveils-first-and-only-subcutaneous-anti-pd-l1-cancer 2024-09-27 06:59:02 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-develops-novel-rybrevant-for-egfr-mutated-advanced-lung-cancer 2024-08-30 03:27:39 daily 0.1 https://demo.pharmafocusasia.com/technotrends/daiichi-sankyo-introduces-first-of-its-kind-enhertu-for-metastatic-breast-cancer 2024-08-30 03:25:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/duke-nus-medical-school-discovered-breakthrough-treatment-for-neurodevelopmental-disorders 2024-08-23 04:36:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novartis-discovered-first-of-its-kind-fabhalta 2024-08-17 03:30:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/attralus-introduces-first-124i-evuzamitide-at-01-for-cardiac-amyloidosis 2024-08-17 03:25:26 daily 0.1 https://demo.pharmafocusasia.com/technotrends/adaptimmune-therapeutics-introduces-breakthrough-tecelra 2024-08-20 23:45:48 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indiana-university-unveils-ground-breaking-new-gene-therapy-for-duchenne-muscular-systrophy 2024-08-03 01:23:54 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ausperbio-therapeutics-introduces-novel-ahb-137-for-chronic-hepatitis-b-treatment 2024-07-26 01:59:01 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sanofi-unveils-ground-breaking-dupixent-therapy-for-chronic-obstructive-pulmonary-disease 2024-07-12 01:44:37 daily 0.1 https://demo.pharmafocusasia.com/technotrends/eli-lilly-introduced-first-of-its-kind-kisunla-for-alzheimers-disease 2024-07-12 01:42:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ligand-pharmaceuticals-develops-novel-ohtuvayre-for-the-treatment-of-chronic-obstructive-pulmonary-disease 2024-07-05 07:19:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aurion-biotech-developed-novel-drug-candidate-aurn001 2024-06-28 04:44:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/dizal-launches-first-in-class-golidocitinib-inhibitor-for-relapsed-or-refractory-peripheral-t-cell-lymphoma 2024-06-28 04:42:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cranbury-pharmaceuticals-introduces-first-of-its-kind-emflaza-for-duchenne-muscular-dystrophy-dmd 2024-06-21 04:01:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/loma-linda-university-health-developed-first-of-its-kind-gene-therapy-for-hemophilia 2024-06-21 03:59:26 daily 0.1 https://demo.pharmafocusasia.com/technotrends/spinogenix-discovered-spg302-a-novel-therapy-for-the-treatment-of-amyotrophic-lateral-sclerosis-als 2024-06-14 04:55:21 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uc-san-diego-health-introduced-novel-therapy-for-melanoma 2024-06-14 04:52:30 daily 0.1 https://demo.pharmafocusasia.com/technotrends/vera-therapeutics-launches-breakthrough-atacicept-therapy-for-immunoglobulin-a-nephropathy 2024-06-07 06:17:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/biogen-develops-qalsody-the-first-therapy-to-treat-a-rare-genetic-form-of-als 2024-06-07 06:14:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/merus-develops-novel-petosemtamab-for-the-treatment-of-head-and-neck-squamous-cell-carcinoma-hnscc 2024-05-31 05:54:29 daily 0.1 https://demo.pharmafocusasia.com/technotrends/roche-introduced-inavolisib-for-the-treatment-of-her2-negative-breast-cancer 2024-05-31 05:52:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/amgen-introduces-first-and-only-imdelltra-t-cell-engager-therapy-for-small-cell-lung-cancer 2024-05-24 01:39:55 daily 0.1 https://demo.pharmafocusasia.com/technotrends/avidity-biosciences-discovers-novel-delpacibart-etedesiran-aoc-1001-for-myotonic-dystrophy-type-1 2024-05-24 01:37:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-launches-first-tivdak-to-treat-recurrent-or-metastatic-cervical-cancer 2024-05-10 04:58:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/the-university-of-texas-md-anderson-cancer-centre-develops-breakthrough-prame-targeted-tcr-nk-cell-therapy 2024-05-10 04:56:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/immunitybio-discovered-novel-anktiva-for-non-muscle-invasive-bladder-cancer 2024-05-03 01:19:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/kura-oncology-introduces-breakthrough-therapy-for-ziftomenib-in-mutant-acute-myeloid-leukaemia 2024-05-03 01:16:50 daily 0.1 https://demo.pharmafocusasia.com/technotrends/genentech-discovered-first-alecensa-treatment-for-early-stage-lung-cancer 2024-04-26 04:08:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johns-hopkins-medicine-developed-novel-treatment-for-leukaemias-and-lymphomas 2024-04-26 04:05:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/dizal-discovered-first-0f-its-kind-sunvozertinib-treatment 2024-04-19 05:33:20 daily 0.1 https://demo.pharmafocusasia.com/technotrends/denovo-biopharma-launches-first-in-class-liafensine-for-treating-depression 2024-04-19 05:31:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/legend-biotech-launched-first-and-only-carvykti-bcma-targeted-car-t-cell-therapy 2024-04-12 01:10:29 daily 0.1 https://demo.pharmafocusasia.com/technotrends/penn-medicine-discovered-novel-technique-for-human-artificial-chromosomes 2024-04-12 01:06:46 daily 0.1 https://demo.pharmafocusasia.com/technotrends/orchard-therapeutics-introduced-breakthrough-lenmeldy-therapy-for-early-onset-metachromatic-leukodystrophy 2024-04-04 04:38:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/merck-develops-first-in-class-winrevair-treatment-for-pulmonary-arterial-hypertension 2024-04-04 04:26:25 daily 0.1 https://demo.pharmafocusasia.com/technotrends/mind-medicine-developed-novel-mm120-for-the-treatment-of-anxiety-disorder 2024-03-28 06:34:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uchicago-medicine-discovered-first-of-its-kind-resmetirom-drug-for-metabolic-liver-disease 2024-03-28 06:32:04 daily 0.1 https://demo.pharmafocusasia.com/technotrends/celltrion-developed-first-of-its-kind-zymfentra-for-the-treatment-of-crohns-disease 2024-03-28 06:30:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/bristol-myers-squibb-introduced-breakthrough-breyanzi-car-t-cell-therapy 2024-03-28 06:28:37 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-discovered-first-of-its-kind-rybrevant-for-the-treatment-of-patients-with-non-small-cell-lung-cancer 2024-03-14 06:56:34 daily 0.1 https://demo.pharmafocusasia.com/technotrends/iovance-biotherapeutics-developed-first-of-its-kind-amtagvi-for-advanced-melanoma 2024-03-08 06:22:27 daily 0.1 https://demo.pharmafocusasia.com/technotrends/bayer-introduces-breakthrough-therapy-bay-2927088-for-non-small-cell-lung-cancer 2024-03-08 06:19:50 daily 0.1 https://demo.pharmafocusasia.com/technotrends/nuvalent-discovered-novel-nvl-520-for-the-treatment-of-non-small-cell-lung-cancer 2024-03-08 06:16:49 daily 0.1 https://demo.pharmafocusasia.com/technotrends/biogen-developed-skyclarys-omaveloxolone-the-first-therapy-to-treat-friedreichs-ataxia 2024-02-29 07:38:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chugai-pharmaceutical-develops-novel-crovalimab-antibody-for-the-treatment-of-paroxysmal-nocturnal-haemoglobinuria 2024-02-29 07:26:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/takeda-discovered-first-of-its-kind-oral-treatment-for-eosinophilic-oesophagitis 2024-02-29 07:24:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/regeneron-pharmaceuticals-introduced-dupixent-first-and-only-treatment-for-children-with-eosinophilic-oesophagitis-eoe 2024-02-23 05:38:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/alector-launched-breakthrough-latozinemab-antibody-for-progranulin-gene-mutation-ftd-grn 2024-02-23 05:36:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/radiomedix-and-orano-moed-discovered-novel-alphamedixtm-for-gastroenteropancreatic-neuroendocrine-tumours 2024-02-23 05:33:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ipsen-developed-first-of-its-kind-for-metastatic-pancreatic-adenocarcinoma 2024-02-23 05:31:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/indiana-university-unveils-first-of-its-kind-gene-therapy-for-amyotrophic-lateral-sclerosis 2024-02-23 05:31:54 daily 0.1 https://demo.pharmafocusasia.com/technotrends/imperial-college-london-introduced-worlds-first-trinetra-glio-blood-test-for-brain-tumour 2024-02-08 04:48:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ensysce-biosciences-launched-ground-breaking-pf614-mpar-product-for-oral-overdose-protection 2024-02-02 06:08:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-missouri-discovered-breakthrough-treatment-for-prostate-cancer 2024-01-25 06:55:21 daily 0.1 https://demo.pharmafocusasia.com/technotrends/shorla-oncology-introduced-novel-sh-105-for-the-treatment-of-breast-and-ovarian-cancer 2024-01-25 06:53:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/vertex-pharmaceuticals-developed-ground-breaking-casgevy-therapy-for-sickle-cell-disease 2024-01-18 06:38:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/the-university-of-texas-at-el-paso-discovered-new-thiophene-f-8-for-leukaemia-and-lymphoma-cancer-cells 2024-01-18 06:25:30 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cg-oncology-unveiled-novel-cretostimogene-grenadenorepvec-for-non-muscle-invasive-bladder-cancer 2024-01-12 05:07:48 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uc-davis-comprehensive-cancer-centre-developed-new-gene-therapy-for-liver-cancer 2024-01-12 05:05:01 daily 0.1 https://demo.pharmafocusasia.com/technotrends/hkumed-discovered-nanomedicine-for-age-related-macular-degeneration-amd-therapy 2024-01-05 06:30:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/blueprint-medicines-introduce-ayvakyt-first-and-only-treatment-for-indolent-systemic-mastocytosis 2023-12-21 06:43:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/roche-diagnostics-developed-novel-elecsys-nfl-test-for-multiple-sclerosis 2023-12-14 06:39:04 daily 0.1 https://demo.pharmafocusasia.com/technotrends/bristol-myers-squibb-discovered-abecma-first-car-t-cell-immunotherapy-for-relapsed-or-refractory-multiple-myeloma 2023-12-14 06:33:47 daily 0.1 https://demo.pharmafocusasia.com/technotrends/osteal-therapeutics-developed-novel-vt-x7-therapy-for-the-treatment-of-periprosthetic-joint-infection 2023-12-14 06:29:28 daily 0.1 https://demo.pharmafocusasia.com/technotrends/johnson-johnson-introduces-breakthrough-tar-200-therapy-for-non-muscle-invasive-bladder-cancer 2023-12-14 06:25:42 daily 0.1 https://demo.pharmafocusasia.com/technotrends/neurocrine-biosciences-introduces-novel-crinecerfont-for-congenital-adrenal-hyperplasia 2023-12-07 05:42:33 daily 0.1 https://demo.pharmafocusasia.com/technotrends/haseltine-lake-kempner-discovered-worlds-first-casgevy-for-the-treatment-of-sickle-cell-disease 2023-12-07 05:34:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/abbvie-introduced-first-of-kind-epcoritamab-for-the-treatment-of-relapsedrefractory-follicular-lymphoma 2023-12-07 05:19:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/springworks-therapeutics-developed-novel-ogsiveo-for-the-treatment-of-desmoid-tumours 2023-12-07 05:15:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/celltrion-developed-first-of-its-kind-zymfentra-for-inflammatory-bowel-disease-treatment 2023-12-07 04:41:51 daily 0.1 https://demo.pharmafocusasia.com/technotrends/vertex-pharmaceuticals-and-crispr-therapeutics-unveil-breakthrough-casgevy-gene-edited-therapy-for-sickle-cell-disease 2023-12-07 04:38:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/imperial-college-london-introduces-casgevy-new-therapy-for-the-blood-disorder-treatment 2023-11-23 07:35:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uva-health-discovered-new-vorasidenib-drug-for-brain-tumour 2023-11-23 07:34:00 daily 0.1 https://demo.pharmafocusasia.com/technotrends/palvella-therapeutics-developed-first-of-its-kind-qtorin-rapamycin-for-microcystic-lymphatic-malformations 2023-11-23 07:31:24 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chimeric-therapeutics-unveils-novel-chm-2101-cell-therapy-for-advanced-gastrointestinal-cancers 2023-11-16 07:33:20 daily 0.1 https://demo.pharmafocusasia.com/technotrends/amicus-therapeutics-developed-breakthrough-pombiliti-treatment-for-pompe-disease 2023-11-16 07:16:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/i-mab-introduced-novel-felzartamab-antibody-for-primary-membranous-nephropathy 2023-11-16 07:13:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/alphamab-oncology-developed-first-of-its-kind-kn026-for-the-treatment-of-gastric-cancer 2023-11-16 07:10:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/coherus-biosciences-and-junshi-biosciences-introduced-first-of-its-kind-loqtorzi-for-the-treatment 2023-11-09 06:24:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/bristol-myers-squibb-developed-first-in-class-lpa1-treatment-for-progressive-pulmonary-fibrosis 2023-11-09 06:18:33 daily 0.1 https://demo.pharmafocusasia.com/technotrends/arrivent-biopharma-discovered-first-of-its-kind-furmonertinib-for-the-treatment-of-non-small-cell-lung-cancer 2023-11-02 06:37:21 daily 0.1 https://demo.pharmafocusasia.com/technotrends/arizon-state-university-discovered-first-of-its-kind-dna-nano-engine 2023-10-26 01:47:25 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cymabay-therapeutics-discovered-novel-seladelpar-for-the-treatment-of-primary-biliary-cholangitis 2023-10-26 01:43:53 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-birmingham-discovered-breakthrough-nanobody-technology 2023-10-24 01:43:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cygenica-introduced-novel-drug-conjugate-in-glioblastoma-multiforme-treatment 2023-10-19 03:11:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/stanford-medicine-discovered-novel-radiation-treatment-machine 2023-10-16 06:27:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/purdue-university-discovered-first-in-class-targeted-microrna-therapy 2023-10-05 04:11:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/nyuad-researchers-developed-novel-tumour-targeting-nanospheres-to-improve-cancer-diagnosis-and-treatment 2023-10-05 04:12:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sandoz-discovered-first-of-its-kind-tyruko-biosimilar-for-multiple-sclerosis 2023-10-05 03:56:55 daily 0.1 https://demo.pharmafocusasia.com/technotrends/avenge-bio-introduced-avb-001-a-novel-cell-therapy 2023-10-05 03:59:52 daily 0.1 https://demo.pharmafocusasia.com/technotrends/zai-lab-introduces-novel-efgartigimod-alfa-injection-for-polyneuropathy-in-china 2023-09-28 03:00:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-launches-first-of-its-kind-abrysvo-vaccine-for-prevention-of-respiratory-syncytial-virus-in-pregnant-individuals 2023-09-28 02:58:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/89bio-discovered-novel-pegozafermin-for-nonalcoholic-steatohepatitis 2023-09-27 23:43:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/kansas-city-university-discovered-new-cancer-treatment 2023-09-27 23:44:46 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-michigan-discovered-new-machine-learning-algorithms-for-antibodies 2023-09-27 06:16:52 daily 0.1 https://demo.pharmafocusasia.com/technotrends/syracuse-university-discovered-breakthrough-peptide-therapy-for-diabetes 2023-09-27 06:12:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-nanoneedle-technology-introduced-for-cancer-treatment 2023-09-26 07:37:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/daiichi-sankyo-discovered-novel-enhertu-for-patients-with-multiple-her2-expressing-cancers 2023-09-26 02:55:26 daily 0.1 https://demo.pharmafocusasia.com/technotrends/janssen-pharmaceuticals-introduces-novel-talvey-for-the-treatment-of-relapsed-and-refractory-multiple-myeloma 2023-09-26 03:15:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/mysthera-therapeutics-develops-first-in-class-autoimmune-disease-therapies 2023-09-07 03:27:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/zai-lab-introduced-breakthrough-repotrectinib-treatment-for-advanced-solid-tumours-in-china 2023-09-07 03:34:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/reflexion-medical-developed-first-of-its-kind-scintix-biology-guided-radiotherapy 2023-09-01 06:39:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/paradigm-therapeutics-discovered-novel-sd-101-treatment-for-epidermolysis-bullosa 2023-09-01 06:35:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/tarsus-pharmaceuticals-discovered-novel-xdemvy-for-demodex-blepharitis-treatment 2023-08-31 06:01:20 daily 0.1 https://demo.pharmafocusasia.com/technotrends/hutchmed-introduces-first-of-its-kind-savolitinib-for-gastric-cancer-treatment 2023-08-31 05:59:04 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-oxford-developed-breakthrough-nanopore-technology-for-protein-variant-detection 2023-08-24 04:23:28 daily 0.1 https://demo.pharmafocusasia.com/technotrends/polpharma-biologics-discovered-first-of-its-kind-natalizumab-biosimilar 2023-08-24 04:14:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/revance-therapeutics-introduces-first-daxxify-for-the-treatment-of-cervical-dystonia 2023-08-24 04:15:30 daily 0.1 https://demo.pharmafocusasia.com/technotrends/janssen-introduces-akeega-first-dual-action-tablet-for-brca-positive-metastatic-castration-resistant-prostate-cancer 2023-08-17 06:03:53 daily 0.1 https://demo.pharmafocusasia.com/technotrends/fujifilm-cellular-dynamics-introduces-novel-human-ipsc-derived-blood-brain-barrier-isogenic-kit 2023-08-17 03:31:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/fosun-pharma-developed-novel-fcn-159-tablet-a-self-developed-mek-inhibitor 2023-08-17 03:34:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/antengene-developed-worlds-first-xpovio-for-the-treatment-of-relapsed-andor-refractory-multiple-myeloma 2023-08-13 10:18:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/biogen-and-sage-therapeutics-introduce-first-of-its-kind-zurzuvae-for-postpartum-depression 2023-08-09 23:53:05 daily 0.1 https://demo.pharmafocusasia.com/technotrends/jacobio-pharma-introduces-novel-kras-g12c-inhibitor-glecirasib-for-pancreatic-cancer 2023-08-09 23:55:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ns-pharma-develops-first-of-its-kind-ns-089-ncnp-02-for-duchenne-muscular-dystrophy 2023-08-04 06:30:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/evogene-developed-breakthrough-chempass-ai-tech-engine-for-target-protein-discovery 2023-08-04 06:35:00 daily 0.1 https://demo.pharmafocusasia.com/technotrends/janssens-novel-bispecific-antibodies-talvey-and-tecvayli-shows-positive-chmp-opinions 2023-08-02 09:42:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/huntsman-cancer-institute-at-the-university-of-utah-develops-novel-prostate-cancer-therapy 2023-07-29 04:00:39 daily 0.1 https://demo.pharmafocusasia.com/technotrends/skyline-therapeutics-develops-skg0106-a-novel-gene-therapy-candidate 2023-07-29 03:56:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/hutchmed-introduces-novel-fruquintinib-in-combination-with-sintilimab-for-advanced-endometrial-cancer 2023-07-26 10:37:30 daily 0.1 https://demo.pharmafocusasia.com/technotrends/renibus-therapeutics-introduced-first-of-its-kind-rbt-1-for-reducing-post-operative-complications 2023-07-21 00:37:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ascentage-pharma-developed-novel-olverembatinib-drug-candidate-to-treat-sdh-deficient-gist 2023-07-13 07:32:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/zoll-developed-first-of-its-kind-remede-system-for-mri-conditional-use 2023-07-07 00:18:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/thermo-fisher-scientific-discovered-novel-immunoassays-for-preeclampsia 2023-07-06 23:55:27 daily 0.1 https://demo.pharmafocusasia.com/technotrends/merus-discovered-novel-zenocutuzumab-for-the-treatment-of-nrg1-pancreatic-cancer 2023-07-05 01:59:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/elevidys-novel-gene-therapy-developed-for-the-tretament-of-duchenne-muscular-dystrophy 2023-06-28 23:43:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-prgn-2012-adenoverse-immunotherapy-discovered-for-recurrent-respiratory-papillomatosis 2023-06-22 06:37:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/grunenthal-developed-novel-resiniferatoxin-for-the-treatment-of-knee-osteoarthritis 2023-06-22 06:32:48 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-omnipod-go-introduced-for-type-2-diabetes 2023-06-22 06:27:39 daily 0.1 https://demo.pharmafocusasia.com/technotrends/boehringer-ingelheim-discovered-novel-spevigo-for-the-treatment-of-psoriasis-flares 2023-06-12 11:50:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sab-biotherapeutics-developed-novel-sab-176-influenza-immunotherapy 2023-05-18 03:49:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cequa-novel-therapy-discovered-for-dry-eye-disease 2023-05-18 03:47:50 daily 0.1 https://demo.pharmafocusasia.com/technotrends/eli-lilly-japan-and-mitsubishi-tanabe-pharma-introduced-mounjaro 2023-05-11 04:18:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/regenxbio-discovered-novel-rgx-202-for-the-tretament-of-duchenne-muscular-dystrophy 2023-04-24 04:07:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/janssen-pharmaceutical-discovered-first-of-its-kind-erleada-apalutamide 2023-04-24 04:07:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/moderna-and-merck-developed-novel-mrna-4157v940-personalised-mrna-cancer-vaccine 2023-04-24 04:06:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-syfovre-developed-for-geographic-atrophy-ga 2023-03-17 02:03:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/abbisko-therapeutics-discovered-novel-csf-1r-inhibitor-pimicotinib-absk021 2023-03-16 06:11:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/loxo-lilly-discovered-novel-jaypirca-pirtobrutinib-for-adult-patients 2023-02-21 01:12:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-ibi351-discovered-for-the-treatment-of-advanced-non-small-cell-lung-cancer 2023-01-22 23:31:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/efruxifermin-novel-therapy-discovered-for-nonalcoholic-steatohepatitis 2023-01-22 23:30:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-avacincaptad-pegol-developed-for-geographic-atrophy 2022-12-06 03:13:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-developed-elranatamab-for-relapsed-or-refractory-multiple-myeloma 2022-12-06 03:12:34 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-setmelanotide-discovered-for-hypothalamic-obesity 2022-12-06 03:11:21 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-ivonescimab-pd-1vegf-bispecific-antibody-developed 2022-12-06 03:10:25 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-cmg901-drug-introduced-for-advanced-gastric-cancer 2022-10-18 03:40:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-retevmo-developed-for-advanced-or-metastatic-solid-tumors 2022-10-18 03:40:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-sirplux-duo-drug-coated-balloon-discovered-for-small-vessel 2022-10-18 03:35:28 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-imbruvica-developed-for-the-treatment-of-chronic 2022-10-31 04:37:38 daily 0.1 https://demo.pharmafocusasia.com/technotrends/auvelity-novel-treatment-discovered-for-the-treatment-of-depressive-disorder 2022-10-31 04:31:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-taletrectinib-developed-for-non-small-cell-lung-cancer 2022-10-31 04:28:37 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-gedatolisib-therapy-discovered-for-the-treatment 2022-10-31 04:26:51 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-talquetamab-developed-for-relapsed-or-refractory-multiple-myeloma 2022-08-01 05:44:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/enhertu-breakthrough-therapy-discovered-for-low-metastatic-breast-cancer 2022-08-01 05:46:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-cms-i-neb-therapy-discovered-for-non-cystic-fibrosis-bronchiectasis-ncfb 2022-08-01 05:49:32 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-inc-discovered-breakthrough-respiratory-syncytial-virus-rsv 2022-08-01 05:50:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-soba-ad-blood-test-developed-to-detect-alzheimers-disease 2022-08-01 05:51:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-monarch-etns-system-discovered-for-drug-resistant-epilepsy-dre 2022-08-01 05:53:30 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-mavacamten-discovered-to-treat-obstructive-hypertrophic-cardiomyopathy-ohcm 2022-04-19 06:55:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-digital-therapeutic-bnt200-discovered 2022-04-19 06:57:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-cardiamp-cell-therapy-system-discovered-for-heart-failure 2022-04-20 23:32:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-patho-seq-assay-discovered-for-the-detection-of-bacteria 2022-04-20 23:44:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/telisotuzumab-vedotin-developed-for-the-tretament-of-non-small-cell-lung-cancer 2022-04-06 23:41:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-patritumab-deruxtecan-discovered-for-the-treatment-of-metastatic 2022-04-06 23:40:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-zetamet-technology-discovered-for-metastatic-bone-cancers 2022-04-06 23:40:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-biology-guided-radiotherapy 2022-02-28 06:58:49 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pear-therapeutics-developed-reset-a-pdt-product-candidate 2022-03-01 01:56:26 daily 0.1 https://demo.pharmafocusasia.com/technotrends/susvimo-breakthrough-therapy-discovered-for-wet-age-related-macular 2022-03-01 02:53:46 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-noninvasive-sonic-beam-device-developed-for-non-invasive-liver-treatment 2022-01-11 01:10:52 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-exo-pdac-assay-discovered-for-early-detection-of-pancreatic-ductal-adenocarcinoma-pdac 2022-01-11 01:09:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-repotrectinib-therapeutic-option-discovered-for-advanced-solid-tumors 2021-12-29 06:34:02 daily 0.1 https://demo.pharmafocusasia.com/technotrends/skytrofa-the-first-therapy-discovered-for-pediatric-growth-hormone-deficiency 2021-12-29 06:37:37 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-simoa-phospho-tau-blood-test-discovered-for-alzheimers-disease 2021-12-29 06:39:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/genentech-developed-breakthrough-therapy-gantenerumab-for-alzheimers-disease 2021-12-29 06:41:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-novilase-interstitial-laser-system-developed-for-breast-cancer 2021-11-23 23:54:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/jardiance-novel-therapy-developed-for-the-treatment-of-patients-with-heart-failure 2021-09-24 01:28:37 daily 0.1 https://demo.pharmafocusasia.com/technotrends/amdizalisib-discovered-for-the-treatment-of-relapsed 2021-09-24 01:27:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-phoenix-therapy-developed-to-treat-ptsd 2021-09-24 01:26:01 daily 0.1 https://demo.pharmafocusasia.com/technotrends/genentech-developed-breakthrough-therapy-venclexta-for-myelodysplastic-syndromes 2021-08-24 00:29:53 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-therapy-toripalimab-discovered-for-the-treatment-of-nasopharyngeal-carcinoma 2021-08-24 00:28:26 daily 0.1 https://demo.pharmafocusasia.com/technotrends/adagrasib-discovered-for-the-treatment-of-advanced-non-small-cell-lung-cancer 2021-08-24 00:27:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/a-novel-oral-therapy-ttp399-discovered-to-treat-type-1-diabetespatients 2021-07-26 06:01:42 daily 0.1 https://demo.pharmafocusasia.com/technotrends/a-breakthrough-therapy-discovered-for-polycythemia-vera-pv 2021-07-26 06:00:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-therapy-bxcl501-developed-for-the-treatment-of-dementia 2021-07-26 05:58:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-therapy-discovered-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma 2021-07-26 05:51:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-therapy-sotorasib-discovered-for-the-treatment-of-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc 2021-06-21 06:09:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-her2-targeted-bispecific-antibody-zanidatamab 2021-06-21 06:08:27 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-elecsys-growth-differentiation-factor-15-assay 2021-06-21 06:00:32 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-apl-106-discovered-for-the-treatment-of-acute-myeloid-leukemia 2021-04-12 06:20:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-cancer-immunotherapy-tiragolumab-discovered-for-the-treatment 2021-04-12 06:18:29 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-xolair-treats-severe-rhinosinusitis-with-nasal-polyps 2021-01-27 02:00:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-oral-therapy-discovered-to-treat-adult-patients-with-metastatic 2020-11-25 06:11:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-therapy-toripalimab-developed-to-treat-nasopharyngeal-carcinoma 2020-11-25 06:10:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/plinabulin-developed-to-prevent-chemotherapy-induced-neutropenia 2020-11-25 06:09:33 daily 0.1 https://demo.pharmafocusasia.com/technotrends/kesimpta-the-first-self-administrated-b-cell-therapy-developed 2020-11-25 06:08:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/gsk-introduces-a-new-anti-bcma-b-cell-maturation-antigen-therapy-blenrep 2020-09-02 00:47:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/axs-12-novel-therapy-discovered-for-the-treatment-of-narcolepsy 2020-09-02 00:45:05 daily 0.1 https://demo.pharmafocusasia.com/technotrends/rozlytrek-entrectinib-the-first-tumour-agnostic-therapy-discovered 2020-09-02 00:42:50 daily 0.1 https://demo.pharmafocusasia.com/technotrends/astrazeneca-introduces-a-breakthrough-therapy-tagrisso 2020-08-24 06:32:44 daily 0.1 https://demo.pharmafocusasia.com/technotrends/merck-discovers-breakthrough-therapy-hif-2a-inhibitor-mk-6482 2020-08-24 06:31:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pevonedistat-novel-therapy-developed-for-the-treatment-of-patients-with-hr-mds 2020-08-24 06:29:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/tecartus-discovered-for-the-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma-mcl 2020-08-24 06:27:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/ctp-543-novel-therapy-introduced-for-the-treatment-of-alopecia-areata 2020-08-24 03:17:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/talaris-therapeutics-develops-novel-cell-therapy 2020-08-24 03:15:15 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-therapy-developed-for-investigational-prenatal-treatment 2020-08-24 03:14:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/gvoke-hypopen-first-autoinjector-discovered-for-severe-hypoglycemia 2020-08-24 03:12:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/gimoti-novel-nasal-spray-developed-for-treatment-of-gastroparesisin 2021-02-24 03:25:42 daily 0.1 https://demo.pharmafocusasia.com/technotrends/crysvita-breakthrough-therapy-developed-for-treatment 2021-01-27 22:39:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/eli-lilly-and-company-launched-new-rapid-acting-insulin-lyumjev 2020-08-24 03:08:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/a-novel-oral-therapy-discovered-to-treat-patients-with-non-cystic-fibrosis-bronchiectasis-ncfbe 2020-08-24 03:06:38 daily 0.1 https://demo.pharmafocusasia.com/technotrends/retevmo-the-first-therapy-developed-for-patients-with-advanced-ret-driven-lung-and-thyroid-cancers 2020-06-26 00:36:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sunovion-launches-kynmobi-for-the-treatment-of-parkinsons-disease-off-episodes 2020-06-26 00:32:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/archer-inc-launches-next-generation-sequencing-ngs-device-to-identify-ntrk-gene-fusions-in-cancer 2020-06-26 00:29:02 daily 0.1 https://demo.pharmafocusasia.com/technotrends/deciphera-pharmaceuticals-develops-qinlock-ripretinib-for-the-treatment 2020-06-26 00:26:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uofl-researchers-discovered-novel-technology-that-shows-promise-fighting-coronavirus 2020-05-29 01:01:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sotaterceptto-treat-patients-with-pulmonary-arterial-hypertension 2020-05-29 01:03:43 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sciex-launched-breakthrough-method-for-gene-therapies 2020-05-29 01:03:50 daily 0.1 https://demo.pharmafocusasia.com/technotrends/4d-printing-technique-developed-to-speed-development-of-new-therapeutics 2020-05-29 01:03:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-plasma-technology-developed-to-treat-multidrug-refractory-bacteria 2020-06-24 05:30:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-anti-malaria-agents-to-block-malaria-transmission 2020-05-29 01:04:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/trinity-researchers-discovered-a-new-breakthrough-for-asthma-patients 2020-05-29 01:04:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/sticky-cancer-cells-could-improve-cancer-prognosis 2020-05-29 01:04:25 daily 0.1 https://demo.pharmafocusasia.com/technotrends/resverlogix-launches-new-drug-for-mace-prevention 2020-05-29 01:03:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-anti-alcoholism-drug-developed-to-treat-cancer 2020-05-29 01:03:27 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aprea-therapeutics-to-treat-myelodysplastic-syndromes 2020-05-29 01:04:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-potential-target-discovered-for-drug-addiction-treatment 2020-05-29 01:04:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/personalized-cancer-monitoring-technology-launched-to-treat-cancer-patients 2020-05-29 01:04:57 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-breakthrough-anticancer-drug-discovered 2020-05-29 01:05:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/the-university-of-cincinnati-researchers-develop-new-treatment-for-brain-cancer 2020-05-29 01:05:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-california-researchers-invent-new-technology-to-cure-cancer 2020-05-29 01:05:28 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-liverpool-researchers-discover-new-technique-in-cell-signaling 2020-05-29 01:06:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-california-researchers-develop-new-enzyme-linked-to-cell-growth-cancer 2020-05-29 01:06:26 daily 0.1 https://demo.pharmafocusasia.com/technotrends/the-university-of-bath-researchers-develop-new-saliva-test-to-detect-synthetic-drug 2020-05-29 01:06:38 daily 0.1 https://demo.pharmafocusasia.com/technotrends/mirum-pharmaceuticals-launch-new-drug-for-treatment-of-alagille-syndrome 2020-05-29 01:06:51 daily 0.1 https://demo.pharmafocusasia.com/technotrends/eli-lilly-launch-new-drug-to-treat-acute-migraine-in-adults 2020-05-29 01:07:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-oral-inhibitor-launched-to-treat-patients-with-histiocytic-neoplasms 2020-05-29 01:07:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/janssen-pharmas-niraparib-treats-patients-with-prostate-cancer 2020-05-29 01:07:30 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uc-santa-cruz-researchers-develop-novel-nanoprobes 2020-05-29 01:10:08 daily 0.1 https://demo.pharmafocusasia.com/technotrends/boehringer-ingelheim-launches-breakthrough-medication-for-treatment-of-ilds 2020-05-29 01:10:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/roches-new-lymphoma-medicine-to-treat-lupus-nephritis 2020-05-29 01:10:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-drug-launched-to-treat-desmoid-tumors-in-adult-patients 2020-05-29 01:10:47 daily 0.1 https://demo.pharmafocusasia.com/technotrends/janssen-launches-rsv-vaccine-to-treat-older-patients 2020-05-29 01:11:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aeglea-biotherapeutics-launches-investigational-therapy-for-treatment-of-arg1-d 2020-05-29 01:11:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/unc-lineberger-researchers-discover-experimental-compound-to-block-lymphoma 2020-05-29 01:11:28 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-drug-introduced-to-treat-primary-hyperoxaluria-type-1 2020-05-29 01:11:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pantheryx-to-launch-new-anti-diarrheal-product-in-cambodia 2019-12-20 23:31:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/university-of-otago-discovered-new-drugs-to-treat-top-infectious-disease 2019-08-27 06:29:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/wvu-researchers-map-crystals-to-enhance-advance-therapies-for-stroke-diabetes-and-dementia 2019-08-27 06:30:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/worlds-fist-of-its-kind-drug-delivery-device-launched-for-precise-dosing-of-cannabis 2019-08-27 06:32:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uics-scientists-develop-a-novel-device-to-screen-advanced-crystalline-materials 2019-08-27 06:33:05 daily 0.1 https://demo.pharmafocusasia.com/technotrends/bayer-launches-breakthrough-therapy-aliqopatm-copanlisib-for-treatment-of-marginal-zone-lymphoma 2019-08-27 06:34:25 daily 0.1 https://demo.pharmafocusasia.com/technotrends/harvard-chemists-developed-synthesis-advance-potent-anti-malignant-tumour-agent 2019-08-27 06:34:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-agent-reactivates-an-immune-call-by-lif-blockade 2019-08-27 06:35:32 daily 0.1 https://demo.pharmafocusasia.com/technotrends/a-3d-printed-clinical-device-intended-to-detect-biomarkers-of-preterm-birth 2019-08-27 06:35:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/cyclica-launches-first-of-its-kind-ligand-designtm 2019-08-27 06:36:43 daily 0.1 https://demo.pharmafocusasia.com/technotrends/york-university-scientists-discover-a-novel-gene-to-prevent-the-spread-of-muscle-cancer 2019-08-27 06:37:09 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uwmadison-school-of-pharmacy-designs-new-compounds-to-fight-deadly-mosquito-transmitted-viruses 2019-05-21 00:11:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/nanopore-based-dna-sequencing-technology-to-diagnose-genetic-disorder-huntingtons-disease 2019-05-21 00:10:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/wistar-scientists-develop-innovative-synthetic-dna-based-cancer-immunotherapy-approach 2019-05-21 00:09:34 daily 0.1 https://demo.pharmafocusasia.com/technotrends/phasebio-to-announce-pb-a-novel-reversal-agent-for-antiplatelet-drug-ticagrelor 2019-04-24 00:38:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/nus-chemists-develop-novel-ratiometric-fluorescent-probe 2019-04-23 23:46:00 daily 0.1 https://demo.pharmafocusasia.com/technotrends/nottingham-university-launches-first-of-its-kind-equipment 2020-05-29 01:03:16 daily 0.1 https://demo.pharmafocusasia.com/technotrends/researchers-develop-dna-encoded-pcsk-inhibitors daily 0.1 https://demo.pharmafocusasia.com/technotrends/molecule-discovery-shows-promise-for-gene-therapy-for-skin-diseases 2019-04-02 06:17:28 daily 0.1 https://demo.pharmafocusasia.com/technotrends/mount-sinai-researchers-determine-significant-beta-cell-proliferation-using-combination daily 0.1 https://demo.pharmafocusasia.com/technotrends/novartis-promacta-approved-as-first-line-treatment-for-severe-aplastic-anemia daily 0.1 https://demo.pharmafocusasia.com/technotrends/nrx-represents-new-class-of-antidepressants-to-decrease-suicidal-thoughts 2019-04-02 06:17:20 daily 0.1 https://demo.pharmafocusasia.com/technotrends/researchers-design-and-develop-new-class-of-molecules-to-halt-tumors 2019-04-02 06:17:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/insmed-announces-arikayce-for-the-treatment-of-mycobacterium daily 0.1 https://demo.pharmafocusasia.com/technotrends/nus-and-harvard-scientists-develop-novel-drug-to-treat-liver-cancer-effectively 2019-04-02 06:17:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-launches-janus-kinase-inhibitor 2019-04-02 06:17:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/alnylams-onpattro-to-treat-patients-with-hereditary-attr-amyloidosis-in-adults- daily 0.1 https://demo.pharmafocusasia.com/technotrends/encorafenib-to-treat-patients-with-brafv-e-mutant-metastatic-colorectal-cancer daily 0.1 https://demo.pharmafocusasia.com/technotrends/daiichi-sankyos-flt-inhibitor-quizartinib-treats-relapsed-refractory-flt-itd-aml daily 0.1 https://demo.pharmafocusasia.com/technotrends/portola-pharmaceuticals-introduces-antidote-for-the-reversal-of-factor-xa-inhibitors daily 0.1 https://demo.pharmafocusasia.com/technotrends/amgen-and-novartis-pharma-collaborate-to-develop-novel-approach-for-migraine-prevention daily 0.1 https://demo.pharmafocusasia.com/technotrends/worlds-first-metal-based-probes-for-detection-of-dopamine-receptors 2018-07-27 01:23:04 daily 0.1 https://demo.pharmafocusasia.com/technotrends/chargepoint-technology-launches-verifi-intelligent-monitoring-hub daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-doptelet-will-soon-be-available-to-control-life-threatening-bleeding daily 0.1 https://demo.pharmafocusasia.com/technotrends/roche-launches-hemlibra-to-treat-haemophilia-a-without-factor-inhibitors daily 0.1 https://demo.pharmafocusasia.com/technotrends/optical-sample-patent-approved-for-breakthrough-cell-culture-management-technology daily 0.1 https://demo.pharmafocusasia.com/technotrends/fda-grants-breakthrough-therapy-designation-for-pti-in-cystic-fibrosis daily 0.1 https://demo.pharmafocusasia.com/technotrends/fda-grants-breakthrough-therapy-designation-to-fennec-pedmark daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-nano-containers-enhance-effect-of-anticancer-therapeutics daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-therapy-lenvima-keytruda-combo-treats-patients daily 0.1 https://demo.pharmafocusasia.com/technotrends/cipher-pharmaceuticals-launches-novel-bactericidal-topical-antibiotic-cream daily 0.1 https://demo.pharmafocusasia.com/technotrends/roches-balovaptan-gets-fdas-breakthrough-therapy-designation daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-diabetes-drugs-sensitise-cancer-cells-to-chemotherapy-agents daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-nanomedicine-prevents-the-development-of-pancreatic-cancer-in-mice daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-sophisticated-microscope-gives-a-boost-to-optogenetic-studies daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-digital-pill-tracks-patients-medication daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-gene-therapy-could-treat-inherited-blindness daily 0.1 https://demo.pharmafocusasia.com/technotrends/merck-announces-first-of-its-kind-filters daily 0.1 https://demo.pharmafocusasia.com/technotrends/pfizer-launches-first-of-its-kind-innovative-technologies-for-hemophilia-patients daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-therapy-designation-to-adcetris daily 0.1 https://demo.pharmafocusasia.com/technotrends/sanofi-and-regenerons-cemiplimab-receives-fda-breakthrough-designation daily 0.1 https://demo.pharmafocusasia.com/technotrends/extrusion-based-drug-implant-production 2019-04-02 06:16:19 daily 0.1 https://demo.pharmafocusasia.com/technotrends/potential-breakthrough-therapy-for-cancer-based-on-pepscans-clips-technology daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-cell-and-gene-therapy-for-knee-osteoarthritis-gets-approval daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-method-for-residual-solvent-characterization-by-gc-vuv 2019-04-02 06:16:13 daily 0.1 https://demo.pharmafocusasia.com/technotrends/magbio-launches-its-novel-cfkapture-kit 2019-04-02 06:16:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/evotec-and-eternygen-to-develop-novel-metabolic-disease-therapy 2019-04-02 06:16:10 daily 0.1 https://demo.pharmafocusasia.com/technotrends/first-of-its-kind-clinical-trial-monitoring-service daily 0.1 https://demo.pharmafocusasia.com/technotrends/fda-grants-breakthrough-therapy-designation-to-toca daily 0.1 https://demo.pharmafocusasia.com/technotrends/anticancer-drugs-breakthrough 2017-07-11 07:49:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/benchling-announces-release-of-its-molecular-biology daily 0.1 https://demo.pharmafocusasia.com/technotrends/fda-approves-novartis-kisqali-femara-co-pack daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-in-lung-cancer-treatment 2017-07-07 02:05:55 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-liquid-biopsy-chip 2019-04-02 06:15:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aptar-pharma-medtech-firms 2019-04-02 06:15:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/heptares-therapeutics daily 0.1 https://demo.pharmafocusasia.com/technotrends/advent-of-high-resolution-d-images-makes-for-a-clearer-view-of-dna-segments 2017-02-20 04:29:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/applying-genetics-new-gene-data-resource-available-in-app-store-now 2020-02-18 04:26:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/battling-superbugs-with-nanotechnology-illumination 2020-02-18 04:21:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/newly-engineered-cas-now-allows-isolated-gene-editing 2020-02-18 04:26:01 daily 0.1 https://demo.pharmafocusasia.com/technotrends/microchips-pose-as-human-kidney-prototypes-to-analyse-pernicity-of-drugs 2019-04-02 06:15:45 daily 0.1 https://demo.pharmafocusasia.com/technotrends/high-speed-production-of-new-antibiotics-that-could-treat-mrsa-and-drug-resistant-tb 2019-04-02 06:15:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/-first-of-its-kind-vaccine-to-control-parasitic-infection-leishmaniasis 2016-04-28 03:39:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/industry-watch-turnaround-from-traditional-ways-pharmaceutical-testing 2016-04-05 03:27:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/israeli-team-finds-two-proteins-that-can-suppress-cancer 2019-04-02 06:15:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/british-scientists-discover-bladder-cancer 2019-04-02 06:15:33 daily 0.1 https://demo.pharmafocusasia.com/technotrends/immunotherapy-treatment 2015-01-20 06:53:22 daily 0.1 https://demo.pharmafocusasia.com/technotrends/needle-free-temperature-stable-insulin-patch-innovation 2015-01-20 06:53:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/novel-microneedle-patch 2015-01-20 06:51:41 daily 0.1 https://demo.pharmafocusasia.com/technotrends/uk-scientist 2015-01-20 06:51:11 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aquavit-pharmaceuticals 2015-01-20 06:50:46 daily 0.1 https://demo.pharmafocusasia.com/technotrends/microcrystalline-cellulose 2019-04-02 06:15:23 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aegis-therapeutics-intravail-technology 2015-01-20 06:49:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/therapeutic-biologics 2015-01-20 06:49:06 daily 0.1 https://demo.pharmafocusasia.com/technotrends/breakthrough-medicine-cancer-treatment 2019-04-02 06:15:17 daily 0.1 https://demo.pharmafocusasia.com/technotrends/world-smallest-pacemaker-implant-medtronic 2015-01-20 06:48:35 daily 0.1 https://demo.pharmafocusasia.com/technotrends/bioasia 2019-04-02 06:15:14 daily 0.1 https://demo.pharmafocusasia.com/technotrends/accela 2019-04-02 06:15:12 daily 0.1 https://demo.pharmafocusasia.com/technotrends/striped-nanoparticles-improve 2015-01-20 06:45:40 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-technology-monitor-crystal-formation 2015-01-20 06:45:18 daily 0.1 https://demo.pharmafocusasia.com/technotrends/nested-nanoparticles 2019-04-02 06:15:07 daily 0.1 https://demo.pharmafocusasia.com/technotrends/device-control-gene-activity-produced 2019-04-02 06:15:05 daily 0.1 https://demo.pharmafocusasia.com/technotrends/biochip-drug-safety 2019-04-02 06:15:03 daily 0.1 https://demo.pharmafocusasia.com/technotrends/proteotuner 2019-04-02 06:15:01 daily 0.1 https://demo.pharmafocusasia.com/technotrends/air-cooled-peltier-accessories 2019-04-02 06:14:59 daily 0.1 https://demo.pharmafocusasia.com/technotrends/smartpill 2019-04-02 06:14:58 daily 0.1 https://demo.pharmafocusasia.com/technotrends/flashquant 2019-04-02 06:14:56 daily 0.1 https://demo.pharmafocusasia.com/technotrends/vesta-thermal-analysis 2019-04-02 06:14:54 daily 0.1 https://demo.pharmafocusasia.com/technotrends/painless-micro-jets 2019-04-02 06:14:52 daily 0.1 https://demo.pharmafocusasia.com/technotrends/counterfeit-drugs 2019-04-02 06:14:50 daily 0.1 https://demo.pharmafocusasia.com/technotrends/aurorab-cancer-drug 2019-04-02 06:14:48 daily 0.1 https://demo.pharmafocusasia.com/technotrends/proimmune-ultimers 2026-05-04 07:21:21 daily 0.1 https://demo.pharmafocusasia.com/technotrends/millipore-mobius 2026-05-04 07:08:33 daily 0.1 https://demo.pharmafocusasia.com/technotrends/compas 2019-04-02 06:14:43 daily 0.1 https://demo.pharmafocusasia.com/technotrends/artel-mvs 2015-03-06 07:34:34 daily 0.1 https://demo.pharmafocusasia.com/technotrends/technotrends/pall-gbk daily 0.1 https://demo.pharmafocusasia.com/technotrends/label-replacement-solution 2019-04-02 06:14:38 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-approach-gpcr 2019-04-02 06:14:36 daily 0.1 https://demo.pharmafocusasia.com/technotrends/new-antibiotic-fights-bacteria 2019-04-02 06:14:34 daily 0.1